Amanda Pace
About Amanda Pace
Amanda Pace is a Director at Bristol Myers Squibb in Seattle, Washington, with extensive experience in chemical and biomolecular engineering and a background in drug formulation and process development.
Current Position at Bristol Myers Squibb
Amanda Pace is currently serving as a Director at Bristol Myers Squibb in Seattle, Washington. She has been associated with the company in various roles, contributing to advancements in drug substance and product formulations. Her expertise is leveraged in overseeing diverse projects and leading development teams to support the company's strategic goals.
Previous Roles at Bristol Myers Squibb
Prior to her current role, Amanda Pace worked as an Associate Director at Bristol Myers Squibb from 2019 to 2020. During this period, she was responsible for leading formulation technical development project activities and played a pivotal role in advancing cell therapy process development and transfer.
Experience at Juno Therapeutics
Amanda Pace was a Senior Process Engineer at Juno Therapeutics, Inc. from 2016 to 2019. In this role, she developed and characterized drug formulations and was actively involved in designing experiments using principles like Design of Experiments (DOE) and Quality by Design (QbD). She utilized her proficiency in JMP analysis tools to conduct statistical analyses.
Tenure at Genentech
Amanda Pace's career at Genentech spanned from 2008 to 2016, where she held various positions such as Engineer II, Senior Research Associate, Research Associate, and Research Assistant. During her time there, she developed monoclonal antibody drug formulations for both intravenous and subcutaneous administration, authored CMC sections for regulatory filings, and supported commercial and marketed products by transferring drug product processes to GMP manufacturing facilities.
Educational Background
Amanda Pace completed her MSE and BS in Chemical and Biomolecular Engineering at The Johns Hopkins University. She studied from 2003 to 2008, gaining both theoretical and practical knowledge that laid the foundation for her extensive career in the biopharmaceutical industry. Her educational background equipped her with the skills necessary for complex problem-solving and innovative drug development.
Key Projects and Presentations
Throughout her career, Amanda Pace has led significant projects and presented at major conferences. She presented at ACS Dallas in 2014 on the topic of Biochemical Technology, focusing on the Correlation of Fc Methionine Oxidation Detection Methods. Her work includes the development of an In vitro UV hemolysis assay to assess high concentration formulations for subcutaneous administration.